{"entity":{"type":"insider","cik":"0001291804","url":"/insider/0001291804","json_url":"/insider/0001291804.json","name":"George Jean","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":66,"n_filings":20,"first":"2005-06-22","last":"2025-08-05","span_basis":"filed_date"},"name_variants":[{"name":"George Jean","source":"filing","n_filings":20,"first_seen":"2005-06-22","last_seen":"2025-08-05"}],"transactions":[{"id":4996681,"accession":"0001641172-25-022247","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001641172-25-022247","line_url":"/filing/0001641172-25-022247#line-2","is_derivative":false,"issuer_cik":"0001291804","issuer_name":"SHOULDER INNOVATIONS, INC.","issuer_ticker":"SI","issuer_name_source":null,"issuer_url":"/issuer/0001291804","owner_cik":null,"owner_name":"Plain Henry A JR; George Jean; Lightstone Ventures II, L.P.; LSV Associates II, LLC; Lightstone Ventures II (A), L.P.","owner_display_name":"Plain Henry A JR","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":266666.0,"shares_display":"266,666","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":3999990.0,"total_display":"3,999,990.00","total_whole":"3,999,990","shares_owned_after":1885136.0,"shares_owned_after_display":"1,885,136","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-01","filed_date":"2025-08-05","scope":"insider"},{"id":5262146,"accession":"0001209191-21-069867","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-21-069867","line_url":"/filing/0001209191-21-069867","is_derivative":false,"issuer_cik":"0001291804","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001291804","owner_cik":null,"owner_name":"Lightstone Ventures II (A), L.P.; LSV Associates, LLC; Lightstone Ventures (A), L.P.; Plain Henry A JR; Lightstone Ventures II, L.P.; Lightstone Ventures, L.P.; George Jean; LSV Associates II, LLC; Carusi Michael A","owner_display_name":"Lightstone Ventures II (A), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48390.0,"shares_display":"48,390","price_per_share":26.60531762760901,"price_display":"26.61","price_state":"stated","total_value":1287431.32,"total_display":"1,287,431.32","total_whole":"1,287,431","shares_owned_after":2110800.0,"shares_owned_after_display":"2,110,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-15","scope":"insider","n_lines":12},{"id":4238644,"accession":"0001209191-21-069135","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-21-069135","line_url":"/filing/0001209191-21-069135","is_derivative":false,"issuer_cik":"0001291804","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001291804","owner_cik":null,"owner_name":"LSV Associates, LLC; Plain Henry A JR; Lightstone Ventures (A), L.P.; Lightstone Ventures, L.P.; George Jean; Lightstone Ventures II, L.P.; LSV Associates II, LLC; Carusi Michael A; Lightstone Ventures II (A), L.P.","owner_display_name":"LSV Associates, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26274.0,"shares_display":"26,274","price_per_share":31.313043312780696,"price_display":"31.31","price_state":"stated","total_value":822718.9,"total_display":"822,718.90","total_whole":"822,719","shares_owned_after":2140002.0,"shares_owned_after_display":"2,140,002","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-10","scope":"insider","n_lines":6},{"id":4238620,"accession":"0001209191-21-069135","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-21-069135","line_url":"/filing/0001209191-21-069135","is_derivative":false,"issuer_cik":"0001291804","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001291804","owner_cik":null,"owner_name":"LSV Associates, LLC; Plain Henry A JR; Lightstone Ventures (A), L.P.; Lightstone Ventures, L.P.; George Jean; Lightstone Ventures II, L.P.; LSV Associates II, LLC; Carusi Michael A; Lightstone Ventures II (A), L.P.","owner_display_name":"LSV Associates, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76905.0,"shares_display":"76,905","price_per_share":32.033049476627006,"price_display":"32.03","price_state":"stated","total_value":2463501.67,"total_display":"2,463,501.67","total_whole":"2,463,502","shares_owned_after":2177065.0,"shares_owned_after_display":"2,177,065","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-09","filed_date":"2021-12-10","scope":"insider","n_lines":6},{"id":4238592,"accession":"0001209191-21-069135","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-069135","line_url":"/filing/0001209191-21-069135","is_derivative":false,"issuer_cik":"0001291804","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001291804","owner_cik":null,"owner_name":"LSV Associates, LLC; Plain Henry A JR; Lightstone Ventures (A), L.P.; Lightstone Ventures, L.P.; George Jean; Lightstone Ventures II, L.P.; LSV Associates II, LLC; Carusi Michael A; Lightstone Ventures II (A), L.P.","owner_display_name":"LSV Associates, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42458.0,"shares_display":"42,458","price_per_share":33.253346130293465,"price_display":"33.25","price_state":"stated","total_value":1411870.57,"total_display":"1,411,870.57","total_whole":"1,411,871","shares_owned_after":2232251.0,"shares_owned_after_display":"2,232,251","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-08","filed_date":"2021-12-10","scope":"insider","n_lines":4},{"id":2040031,"accession":"0000899243-20-020030","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-020030","line_url":"/filing/0000899243-20-020030","is_derivative":false,"issuer_cik":"0001291804","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001291804","owner_cik":null,"owner_name":"Lightstone Ventures (A), L.P.; Lightstone Ventures, L.P.; Lightstone Ventures II (A), L.P.; Plain Henry A JR; Lightstone Ventures II, L.P.; LSV Associates, LLC; LSV Associates II, LLC; Carusi Michael A; George Jean","owner_display_name":"Lightstone Ventures (A), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":7600000.0,"total_display":"7,600,000.00","total_whole":"7,600,000","shares_owned_after":378000.0,"shares_owned_after_display":"378,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-21","filed_date":"2020-07-22","scope":"insider","n_lines":2},{"id":8101175,"accession":"0001209191-19-039550","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-19-039550","line_url":"/filing/0001209191-19-039550#line-7","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001291804","owner_name":"George Jean","owner_display_name":"George Jean","owner_url":"/insider/0001291804","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11812.0,"shares_display":"11,812","price_per_share":41.17,"price_display":"41.17","price_state":"stated","total_value":486300.04,"total_display":"486,300.04","total_whole":"486,300","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-28","filed_date":"2019-06-28","scope":"insider"},{"id":8101171,"accession":"0001209191-19-039550","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-039550","line_url":"/filing/0001209191-19-039550#line-6","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001291804","owner_name":"George Jean","owner_display_name":"George Jean","owner_url":"/insider/0001291804","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25688.0,"shares_display":"25,688","price_per_share":39.16,"price_display":"39.16","price_state":"stated","total_value":1005942.08,"total_display":"1,005,942.08","total_whole":"1,005,942","shares_owned_after":15562.0,"shares_owned_after_display":"15,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-26","filed_date":"2019-06-28","scope":"insider"},{"id":4198929,"accession":"0001209191-17-066163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-066163","line_url":"/filing/0001209191-17-066163#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001291804","owner_name":"George Jean","owner_display_name":"George Jean","owner_url":"/insider/0001291804","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105122.0,"shares_display":"105,122","price_per_share":35.73,"price_display":"35.73","price_state":"stated","total_value":3756009.06,"total_display":"3,756,009.06","total_whole":"3,756,009","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-15","filed_date":"2017-12-18","scope":"insider"},{"id":2379222,"accession":"0001209191-16-151236","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-151236","line_url":"/filing/0001209191-16-151236","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001291804","owner_name":"George Jean","owner_display_name":"George Jean","owner_url":"/insider/0001291804","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":420576.0,"shares_display":"420,576","price_per_share":38.155571787263185,"price_display":"38.16","price_state":"stated","total_value":16047317.76,"total_display":"16,047,317.76","total_whole":"16,047,318","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-17","filed_date":"2016-11-18","scope":"insider","n_lines":2},{"id":2379214,"accession":"0001209191-16-151236","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-151236","line_url":"/filing/0001209191-16-151236#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001291804","owner_name":"George Jean","owner_display_name":"George Jean","owner_url":"/insider/0001291804","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32929.0,"shares_display":"32,929","price_per_share":41.39,"price_display":"41.39","price_state":"stated","total_value":1362931.31,"total_display":"1,362,931.31","total_whole":"1,362,931","shares_owned_after":420576.0,"shares_owned_after_display":"420,576","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-16","filed_date":"2016-11-18","scope":"insider"},{"id":2746300,"accession":"0001209191-16-144718","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-144718","line_url":"/filing/0001209191-16-144718#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001291804","owner_name":"George Jean","owner_display_name":"George Jean","owner_url":"/insider/0001291804","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":857145.0,"shares_display":"857,145","price_per_share":35.5,"price_display":"35.50","price_state":"stated","total_value":30428647.5,"total_display":"30,428,647.50","total_whole":"30,428,648","shares_owned_after":453505.0,"shares_owned_after_display":"453,505","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-30","filed_date":"2016-10-04","scope":"insider"},{"id":8915022,"accession":"0001104659-15-049023","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001104659-15-049023","line_url":"/filing/0001104659-15-049023","is_derivative":false,"issuer_cik":"0001291804","issuer_name":"CATABASIS PHARMACEUTICALS INC","issuer_ticker":"CATB","issuer_name_source":null,"issuer_url":"/issuer/0001291804","owner_cik":"0001291804","owner_name":"George Jean","owner_display_name":"George Jean","owner_url":"/insider/0001291804","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":258776.0,"shares_display":"258,776","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":3105312.0,"total_display":"3,105,312.00","total_whole":"3,105,312","shares_owned_after":1133943.0,"shares_owned_after_display":"1,133,943","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-30","filed_date":"2015-06-30","scope":"insider","n_lines":3},{"id":8783027,"accession":"0001209191-15-004612","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-004612","line_url":"/filing/0001209191-15-004612#line-3","is_derivative":false,"issuer_cik":"0001291804","issuer_name":"Zeltiq Aesthetics Inc","issuer_ticker":"ZLTQ","issuer_name_source":null,"issuer_url":"/issuer/0001291804","owner_cik":"0001291804","owner_name":"George Jean","owner_display_name":"George Jean","owner_url":"/insider/0001291804","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17483.0,"shares_display":"17,483","price_per_share":29.2564,"price_display":"29.26","price_state":"stated","total_value":511489.6412,"total_display":"511,489.64","total_whole":"511,490","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-15","filed_date":"2015-01-16","scope":"insider"},{"id":6272707,"accession":"0001209191-14-074229","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-074229","line_url":"/filing/0001209191-14-074229#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001291804","owner_name":"George Jean","owner_display_name":"George Jean","owner_url":"/insider/0001291804","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8778.0,"shares_display":"8,778","price_per_share":40.11,"price_display":"40.11","price_state":"stated","total_value":352085.58,"total_display":"352,085.58","total_whole":"352,086","shares_owned_after":1310650.0,"shares_owned_after_display":"1,310,650","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-09","filed_date":"2014-12-10","scope":"insider"},{"id":6272705,"accession":"0001209191-14-074229","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-074229","line_url":"/filing/0001209191-14-074229","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001291804","owner_name":"George Jean","owner_display_name":"George Jean","owner_url":"/insider/0001291804","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88629.0,"shares_display":"88,629","price_per_share":45.37270994821108,"price_display":"45.37","price_state":"stated","total_value":4021337.91,"total_display":"4,021,337.91","total_whole":"4,021,338","shares_owned_after":1819920.0,"shares_owned_after_display":"1,819,920","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-08","filed_date":"2014-12-10","scope":"insider","n_lines":2},{"id":7015976,"accession":"0001209191-14-066387","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-066387","line_url":"/filing/0001209191-14-066387#line-3","is_derivative":false,"issuer_cik":"0001291804","issuer_name":"Zeltiq Aesthetics Inc","issuer_ticker":"ZLTQ","issuer_name_source":null,"issuer_url":"/issuer/0001291804","owner_cik":"0001291804","owner_name":"George Jean","owner_display_name":"George Jean","owner_url":"/insider/0001291804","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17483.0,"shares_display":"17,483","price_per_share":25.1461,"price_display":"25.15","price_state":"stated","total_value":439629.2663,"total_display":"439,629.27","total_whole":"439,629","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-04","scope":"insider"},{"id":7035259,"accession":"0001209191-14-062654","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-062654","line_url":"/filing/0001209191-14-062654#line-2","is_derivative":false,"issuer_cik":"0001291804","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001291804","owner_cik":"0001291804","owner_name":"George Jean","owner_display_name":"George Jean","owner_url":"/insider/0001291804","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":2110082.0,"shares_owned_after_display":"2,110,082","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-07","filed_date":"2014-10-09","scope":"insider"},{"id":6876381,"accession":"0001209191-14-049782","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-049782","line_url":"/filing/0001209191-14-049782","is_derivative":false,"issuer_cik":"0001291804","issuer_name":"Zeltiq Aesthetics Inc","issuer_ticker":"ZLTQ","issuer_name_source":null,"issuer_url":"/issuer/0001291804","owner_cik":"0001291804","owner_name":"George Jean","owner_display_name":"George Jean","owner_url":"/insider/0001291804","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29157.0,"shares_display":"29,157","price_per_share":20.0905,"price_display":"20.09","price_state":"stated","total_value":585778.7085,"total_display":"585,778.71","total_whole":"585,779","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-31","filed_date":"2014-07-31","scope":"insider","n_lines":2},{"id":6527369,"accession":"0001209191-14-044176","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-044176","line_url":"/filing/0001209191-14-044176#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001291804","owner_name":"George Jean","owner_display_name":"George Jean","owner_url":"/insider/0001291804","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10320.0,"shares_display":"10,320","price_per_share":35.01,"price_display":"35.01","price_state":"stated","total_value":361303.2,"total_display":"361,303.20","total_whole":"361,303","shares_owned_after":1903063.0,"shares_owned_after_display":"1,903,063","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-26","filed_date":"2014-06-27","scope":"insider"}],"collapsed":true,"next_cursor":"2014-06-26|6527369","ledger_fault":false,"count":{"value":35,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":35},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001699350","name":"SHOULDER INNOVATIONS, INC.","url":"/issuer/0001699350","role":"Other","n_filings":1,"first_seen":"2025-08-05","last_seen":"2025-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001810182","name":"ALX ONCOLOGY HOLDINGS INC","url":"/issuer/0001810182","role":"Ten percent owner","n_filings":3,"first_seen":"2020-07-22","last_seen":"2021-12-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001280600","name":"ACCELERON PHARMA INC","url":"/issuer/0001280600","role":"Director","n_filings":8,"first_seen":"2014-05-06","last_seen":"2019-06-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001454789","name":"CATABASIS PHARMACEUTICALS INC","url":"/issuer/0001454789","role":"Director","n_filings":1,"first_seen":"2015-06-30","last_seen":"2015-06-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001415336","name":"Zeltiq Aesthetics Inc","url":"/issuer/0001415336","role":"Director, Ten percent owner, Other","n_filings":5,"first_seen":"2013-11-18","last_seen":"2015-01-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001496671","name":"Calithera Biosciences, Inc.","url":"/issuer/0001496671","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2014-10-09","last_seen":"2014-10-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001145404","name":"CRITICAL THERAPEUTICS INC","url":"/issuer/0001145404","role":"Director","n_filings":1,"first_seen":"2005-06-22","last_seen":"2005-06-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001291804","retrieved_at":"2026-08-24T20:50:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}